RGNX Cash-Secured Put Strategy
RGNX (REGENXBIO Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
REGENXBIO Inc. is a biotechnology company operating in the clinical stage, dedicated to developing gene therapy candidates. These therapies are designed to introduce genes into cells, aiming either to rectify genetic deficiencies or to stimulate the body's own cells to produce therapeutic proteins or antibodies to combat diseases. Central to its therapeutic development is the proprietary NAV Technology Platform, an adeno-associated virus-based gene delivery system. The company's primary investigational asset, RGX-314, is currently in Phase III clinical trials for treating wet age-related macular degeneration. Its pipeline also includes RGX-121 and RGX-111, both in Phase I/II trials for mucopolysaccharidosis type II and type I, respectively; RGX-181, which is in preclinical development for late-infantile neuronal ceroid lipofuscinosis type II disease; RGX-202, undergoing Phase I/II evaluation for Duchenne muscular dystrophy; and RGX-381, at the preclinical stage for addressing the ocular manifestations of CLN2 disease. In addition to its internal programs, REGENXBIO Inc. licenses its NAV Technology Platform to other biotech and pharmaceutical enterprises.
RGNX (REGENXBIO Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $564.0M, a beta of 0.94 versus the broader market, a 52-week range of 5.455-16.19, average daily share volume of 1.8M, a public-listing history dating back to 2015, approximately 371 full-time employees. These structural characteristics shape how RGNX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.94 places RGNX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a cash-secured put on RGNX?
A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.
RGNX snapshot
As of August 14, 2026, spot at $10.84, ATM IV 146.80%, IV rank 27.53%, expected move 42.09%. The cash-secured put on RGNX below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 7-day expiry.
Why this cash-secured put structure on RGNX specifically: RGNX IV at 146.80% is on the cheap side of its 1-year range, which means a premium-selling RGNX cash-secured put collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 42.09% (roughly $4.56 on the underlying). The 7-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RGNX expiries trade a higher absolute premium for lower per-day decay. Position sizing on RGNX should anchor to the underlying notional of $10.84 per share and to the trader's directional view on RGNX stock.
RGNX cash-secured put setup
The RGNX cash-secured put below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RGNX at $10.84 on that close, the first option leg uses a $10.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RGNX chain at a 7-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RGNX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Sell 1 | Put | $10.00 | $0.61 |
RGNX cash-secured put risk and reward
- Net Premium / Debit
- +$61.00
- Max Profit (per contract)
- $61.00
- Max Loss (per contract)
- -$938.00
- Breakeven(s)
- $9.39
- Risk / Reward Ratio
- 0.065
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.
RGNX cash-secured put payoff curve
Modeled P&L at expiration across a range of underlying prices for the cash-secured put on RGNX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$938.00 |
| $2.41 | -77.8% | -$698.43 |
| $4.80 | -55.7% | -$458.86 |
| $7.20 | -33.6% | -$219.30 |
| $9.59 | -11.5% | +$20.27 |
| $11.99 | +10.6% | +$61.00 |
| $14.38 | +32.7% | +$61.00 |
| $16.78 | +54.8% | +$61.00 |
| $19.18 | +76.9% | +$61.00 |
| $21.57 | +99.0% | +$61.00 |
When traders use cash-secured put on RGNX
Cash-secured puts on RGNX earn premium while a trader waits to acquire RGNX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RGNX.
RGNX thesis for this cash-secured put
The market-implied 1-standard-deviation range for RGNX extends from approximately $6.28 on the downside to $15.40 on the upside. A RGNX cash-secured put lets a trader earn premium while waiting to acquire RGNX at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current RGNX IV rank near 27.53% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RGNX at 146.80%. As a Healthcare name, RGNX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RGNX-specific events.
RGNX cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RGNX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RGNX alongside the broader basket even when RGNX-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on RGNX carry tail risk when realized volatility exceeds the implied move; review historical RGNX earnings reactions and macro stress periods before sizing. Always rebuild the position from current RGNX chain quotes before placing a trade.
Frequently asked questions
- What is a cash-secured put on RGNX?
- A cash-secured put on RGNX is the cash-secured put strategy applied to RGNX (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With RGNX stock at $10.84 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed RGNX chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are RGNX cash-secured put max profit and max loss calculated?
- Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the RGNX cash-secured put priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 146.80%), the computed maximum profit is $61.00 per contract and the computed maximum loss is -$938.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RGNX cash-secured put?
- The breakeven for the RGNX cash-secured put priced on this page is roughly $9.39 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The RGNX market-implied 1-standard-deviation expected move in the same options snapshot is approximately 42.09%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a cash-secured put on RGNX?
- Cash-secured puts on RGNX earn premium while a trader waits to acquire RGNX stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning RGNX.
- How does current RGNX implied volatility affect this cash-secured put?
- RGNX ATM IV is at 146.80% with IV rank near 27.53%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.